Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment

Cannabis and Cannabinoid Research

Volumn 1, Issue 1, 2016, Pages 81-89

  Wei, Don ^a   Dinh, Drake ^a   Lee, Dayeon ^a   Li, Dandan ^a,b   Anguren, Allison ^a   Moreno Sanz, Guillermo ^a   Gall, Christine M ^a   Piomelli, Daniele ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

autism spectrum disorders; CB1; fatty acid amide hydrolase; Fragile X Syndrome; social approach

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; OXYTOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; ENZYME INHIBITION; FRAGILE X SYNDROME; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REWARD; SOCIAL IMPAIRMENT; SOCIAL INTERACTION; SOCIAL PROBLEM;

EID: 84995483491     PISSN: None     EISSN: 23788763     Source Type: Journal    
DOI: 10.1089/can.2015.0008     Document Type: Article

References (48)

1. Lord C, Cook EH, Leventhal BL, et al. Autism spectrum disorders. Neuron. 2000;28:355-363.
2. Diagnostic and statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association: Arlington, VA, 2013.
3. Adolphs R. Cognitive neuroscience of human social behaviour. Nat Rev Neurosci. 2003;4:165-178.
4. Chevallier C, Kohls G, Troiani V, et al. The social motivation theory of autism. Trends Cogn Sci. 2012;16:231-239.
5. Stanley DA, Adolphs R. Toward a neural basis for social behavior. Neuron. 2013;80:816-826.
6. Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron. 2010;65:768-779.
7. Dölen G, Darvishzadeh A, Huang KW, et al. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature. 2013;501:179-184.
8. Modi ME, Young LJ. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Horm Behav. 2012;61:340-350.
9. Pen agarikano O, Lazaro MT, Lu X-H, et al. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Sci Transl Med. 2015;7:271ra8.
10. Yatawara CJ, Einfeld SL, Hickie IB, et al. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry. October 2015. [Epub ahead of print]; DOI:10.1038/mp.2015.162.
11. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003;4:873-884.
12. Piomelli D. More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology. 2014;76:228-234.
13. Cassano T, Gaetani S, Macheda T, et al. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology. 2011;214:465-476.
14. Trezza V, Damsteegt R, Manduca A, et al. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci. 2012;32:14899-14908.
15. Wei D, Lee D, Cox CD, et al. Endocannabinoid signaling mediates oxytocindriven social reward. Proc Natl Acad Sci USA. 2015;112:14084-14089.
16. Tart CT. Marijuana intoxication: common experiences. Nature. 1970;226:701-704.
17. Salzman C, Van der Kolk BA, Shader RI. Marijuana and hostility in a smallgroup setting. Am J Psychiatry. 1976;133:1029-1033.
18. Chakrabarti B, Baron-Cohen S. Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces. Mol Autism. 2011;2:10.
19. Kathuria S, Gaetani S, Fegley D, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2002;9:76-81.
20. McFarlane HG, Kusek GK, Yang M, et al. Autism-like behavioral phenotypes in BTBR T+ tf/J mice. Genes Brain Behav. 2008;7:152-163.
21. Silverman JL, Smith DG, Rizzo SJS, et al. Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med. 2012;4:131ra51.
22. Moy SS, Nadler JJ, Young NB, et al. Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav. 2009; 8:129-142.
23. Mineur YS, Huynh LX, Crusio WE. Social behavior deficits in the Fmr1 mutant mouse. Behav Brain Res. 2006;168:172-175.
24. Kaufmann WE, Cortell R, Kau ASM, et al. Autism spectrum disorder in fragile X syndrome: communication, social interaction, and specific behaviors. Am J Med Genet. 2004;129A:225-234.
25. Fegley D, Gaetani S, Duranti A, et al. Characterization of the fatty-acid amide hydrolase inhibitor URB597: effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 2005;313:352-358.
26. Clapper JR, Vacondio F, King AR, et al. A second generation of carbamatebased fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem. 2009;4:1505-1513.
27. Astarita G, Piomelli D. Lipidomic analysis of endocannabinoid metabolism in biological samples. J Chromatogr B. 2009;877:2755-2767.
28. Jung K-M, Sepers M, Henstridge CM, et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun. 2012;3:1080.
29. McMahon LR, Koek W. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. Eur J Pharmacol. 2007;569:70-76.
30. Fraser GA. The use of a synthetic cannabinoid in the management of Treatment-Resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009;15:84-88.
31. Moreira FA, Kaiser N, Monory K, et al. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology. 2008;54:141-150.
32. Haller J, Varga B, Ledent C, et al. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci. 2004;19:1906-1912.
33. Harkany T, Guzmán M, Galve-Roperh I, et al. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci. 2007;28:83-92.
34. Földy C, Malenka RC, Südhof TC. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron. 2013;78:498-509.
35. Sciolino NR, Bortolato M, Eisenstein SA, et al. Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience. 2010;168:371-386.
36. Kerr DM, Downey L, Conboy M, et al. Alterations in the endocannabinoid system in the rat valproic acid model of autism. Behav Brain Res. 2013;30:680-695.
37. Litvin Y, Phan A, Hill MN, et al. CB1 receptor signaling regulates social anxiety and memory. Genes Brain Behav. 2013;12:479-489.
38. Terzian ALB, Micale V, Wotjak CT. Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. Eur J Neurosci. 2014;40:2293-2298.
39. Trezza V, Vanderschuren LJ. Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology. 2008; 197:217-227.
40. Morena M, Patel S, Bains JS, et al. Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology. 2016;41:80-102.
41. Patel S, Roelke CT, Rademacher DJ, et al. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamicpituitary-adrenal axis. Endocrinology. 2004;145:5431-5438.
42. Bortolato M, Piomelli D. The endocannabinoid system and anxiety responses. Handbook of Behavioral Neuroscience. 2008;17:303-324.
43. Klugmann M, Goepfrich A, Friemel CM, et al. AAV-mediated overexpression of the CB1 receptor in the mPFC of adult rats alters cognitive flexibility, social behavior, and emotional reactivity. Front Behav Neurosci. 2011;5:37.
44. Silverman JL, Yang M, Lord C, et al. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11:490-502.
45. Silverman JL, Yang M, Turner SM, et al. Low stress reactivity and neuroendocrine factors in the BTBR T + tf/J mouse model of autism. Neuroscience. 2010;171:1197-1208.
46. Pearson BL, Bettis JK, Meyza KZ, et al. Absence of social conditioned place preference in BTBR T + tf/J mice: relevance for social motivation testing in rodent models of autism. Behav Brain Res. 2012;233:99-104.
47. Yizhar O, Fenno LE, Prigge M, et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature. 2011;477:171-178.
48. Han S, Tai C, Jones CJ, et al. Enhancement of inhibitory neurotransmission by GABAA receptors having a2,3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron. 2014;81:1282-1289.